ADCYAP1R1 explained

Pituitary adenylate cyclase-activating polypeptide type I receptor also known as PAC1, is a protein that in humans is encoded by the ADCYAP1R1 gene. This receptor binds pituitary adenylate cyclase activating peptide.[1] [2]

Function

PAC1 is a membrane-associated protein and shares significant homology with members of the G-protein coupled class B glucagon/secretin receptor family.[3] This receptor mediates diverse biological actions of adenylate cyclase activating polypeptide 1 and is positively coupled to adenylate cyclase. Alternative splicing of two exons of this gene generates four major splice variants, but their full-length nature has not been determined.[4] PAC1 is expressed in the adrenal medulla, pancreatic acini, uterus, myenteric plexus and brain.[5] [6] [7] It is also expressed in the trigeminal, otic and superior cervical ganglia (prejunctional) and cerebral arteries (postjunctional).[8]

Further reading

External links

Notes and References

  1. Ogi K, Miyamoto Y, Masuda Y, Habata Y, Hosoya M, Ohtaki T, Masuo Y, Onda H, Fujino M . Molecular cloning and functional expression of a cDNA encoding a human pituitary adenylate cyclase activating polypeptide receptor . Biochemical and Biophysical Research Communications . 196 . 3 . 1511–21 . Nov 1993 . 7902709 . 10.1006/bbrc.1993.2423 .
  2. Vaudry D, Gonzalez BJ, Basille M, Yon L, Fournier A, Vaudry H . Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions . Pharmacological Reviews . 52 . 2 . 269–324 . Jun 2000 . 10835102 .
  3. Wang J, Song X, Zhang D, Chen X, Li X, Sun Y, Li C, Song Y, Ding Y, Ren R, Harrington EH, Hu LA, Zhong W, Xu C, Huang X, Wang HW, Ma Y . Cryo-EM structures of PAC1 receptor reveal ligand binding mechanism . Cell Res. . 30. 5. 436–445. 2020 . 32047270 . 10.1038/s41422-020-0280-2 . 7196072 . free .
  4. Web site: Entrez Gene: ADCYAP1R1 adenylate cyclase activating polypeptide 1 (pituitary) receptor type I.
  5. Reubi JC . In vitro evaluation of VIP/PACAP receptors in healthy and diseased human tissues. Clinical implications . Annals of the New York Academy of Sciences . 921 . 1–25 . 2000 . 1 . 11193811 . 10.1111/j.1749-6632.2000.tb06946.x . 2000NYASA.921....1R . 21204750 .
  6. Reubi JC, Läderach U, Waser B, Gebbers JO, Robberecht P, Laissue JA . Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin . Cancer Research . 60 . 11 . 3105–12 . Jun 2000 . 10850463 .
  7. Yon L, Breault L, Contesse V, Bellancourt G, Delarue C, Fournier A, Lehoux JG, Vaudry H, Gallo-Payet N . Localization, characterization, and second messenger coupling of pituitary adenylate cyclase-activating polypeptide receptors in the fetal human adrenal gland during the second trimester of gestation . The Journal of Clinical Endocrinology and Metabolism . 83 . 4 . 1299–305 . Apr 1998 . 10.1210/jcem.83.4.4690 . 9543159 .
  8. Knutsson M, Edvinsson L . Distribution of mRNA for VIP and PACAP receptors in human cerebral arteries and cranial ganglia . NeuroReport . 13 . 4 . 507–9 . Mar 2002 . 11930171 . 10.1097/00001756-200203250-00030 . 30329669 .